Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective

Soumya Basu, Gayathri Ashok, Reetika Debroy, Sudha Ramaiah, Paul Livingstone, Anand Anbarasu*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

22 Citations (Scopus)

Abstract

The coronavirus disease (COVID-19) threat is subsiding through extensive vaccination worldwide. However, the pandemic imposed major disruptions in global immunization programs and has aggravated the risks of vaccine-preventable disease (VPD) outbreaks. Particularly, lower-middle-income regions with minimal vaccine coverage and circulating vaccine-derived viral strains, such as polio, suffered additional burden of accumulated zero-dose children, further making them vulnerable to VPDs. However, there is no compilation of routine immunization disruptions and recovery prospects. There is a noticeable change in the routine vaccination coverage across different phases of the pandemic in six distinct global regions. We have summarized the impact of COVID-19 on routine global vaccination programs and also identified the prospects of routine immunization to combat COVID-like outbreaks.

Original languageEnglish
Article number2199656
JournalHuman Vaccines and Immunotherapeutics
Volume19
Issue number1
Early online date20 Apr 2023
DOIs
Publication statusPublished - 20 Apr 2023

Keywords

  • COVID-19
  • disruption
  • routine immunization
  • vaccines

Cite this